India’s Draft Guidelines For COVID-19 Vaccines Follow WHO, US Lead
Primary Endpoint Efficacy 50%, Secondary Up To 30%
India has rolled out draft guidelines for development of vaccines with special focus on COVID-19 vaccines, drawing from those of other regulatory bodies and the WHO. Experts suggest the primary efficacy endpoint of minimum 50% is acceptable given that vaccines against respiratory diseases are difficult to develop though not necessarily enough to snuff out a pandemic.
